Many small / macro molecule-based STING pathway modulators are currently being evaluated
In recent years, the concept of STING pathway targetingtherapeutics has generated a lot of enthusiasm within the medical sciencecommunity. The growing popularity of this therapeutic technique has not onlygarnered the interest of several medical researchers (reflected in theincreasing volume of scientific literature (1,000+ articles published since2015) on this subject), but also industry stakeholders focused on drugdevelopment (evident in the growing number of clinical trials and the grantsawarded for STING focused projects in the recent past).
To order this 310+ page report, which features 170+ figuresand 200+ tables, please visit this - https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
The USD 2.8 billion (by 2030) financial opportunitywithin the STING pathway targeting technologies market has been analysed acrossthe following segments:
§ Types of Payment
§ Upfront Payments
§ Milestone Payments
§ Type of STING Modulator
§ Agonist
§ Antagonist
§ Key Therapeutic Area(s)
§ Oncological Disorders
§ Inflammatory Disorders
§ Infectious Diseases
§ Others
§ Route of Administration
§ Intratumoral
§ Intravenous
§ Oral
§ Subcutaneous
§ Others
§ Type of Molecule
§ Non-nucleotide
§ Cyclic Dinucleotide
§ Live Biotherapeutics
§ Oncolytic Peptides
§ Synthetic Peptides
§ Others
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
The STINGPathway Targeting Therapeutics and Technologies,2020-2030. report features the following companies, which weidentified to be key players in this domain:
§ Aduro Biotech
§ Bristol Myers Squibb
§ Eisai
§ GlaxoSmithKline
§ ImmuneSensorTherapeutics
§ Merck
§ Noxopharm
§ Spring BankPharmaceuticals
§ Synlogic
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. STING Pathway Targeting Therapeutics:Current Market Landscape
5. STING Pathway Targeting Technologies:Current Market landscape
6. Company Profiles
7. Academic Grant Analysis
8. STING Related Initiatives of BigPharmaceutical Players
9. Start-up Health Indexing
10. Publication Analysis
11. Partnerships and Collaborations
12. Funding and Investment Analysis
13. Market Sizing and Opportunity Analysis
14. Executive Insights
15. Concluding Remarks
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies andOrganizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
